These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2598325)

  • 21. Antihypertensive dihydropyridines with 1,4,4-trisubstitution.
    Kukla MJ; Breslin HJ; Gill A
    J Med Chem; 1990 Jan; 33(1):223-8. PubMed ID: 2296021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antihypertensive activity of 1,4-dihydropyridine derivatives with a 4-(disubstituted phenyl) ring and an aminoalkyl ester group: highly potent and long-lasting calcium antagonists.
    Kanno H; Yamaguchi H; Okamiya Y; Sunakawa K; Takeshita T; Naruchi T
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2049-54. PubMed ID: 1423758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antiallergic activity of N-[4-(4-diphenylmethyl-1-piperazinyl)butyl]-1,4-dihydro-4-oxopyridine-3 - carboxamides.
    Nishikawa Y; Shindo T; Ishii K; Nakamura H; Kon T; Uno H; Matsumoto J
    Chem Pharm Bull (Tokyo); 1989 May; 37(5):1256-9. PubMed ID: 2483534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
    Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R
    Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antihypertensive activities of new 1,4-dihydropyridine containing nitroimidazolyl substituent with a nitrooxy group at the 3-ester position.
    Shafiee A; Rastkary N; Jorjani M; Shafaghi B
    Arch Pharm (Weinheim); 2002 Mar; 335(2-3):69-76. PubMed ID: 12043457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
    Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
    Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of 3H-nitrendipine binding in rat aortic and cerebral cortex membranes by the new dihydropyridine calcium antagonist benidipine hydrochloride.
    Ishii A
    Arzneimittelforschung; 1989 Dec; 39(12):1546-50. PubMed ID: 2624603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
    Kanda A; Haruno A; Miyake H; Nagasaka M
    J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on dihydropyridines. III. Synthesis of 4,7-dihydrothieno [2,3-b]-pyridines with vasodilator and antihypertensive activities.
    Adachi I; Yamamori T; Hiramatsu Y; Sakai K; Mihara S; Kawakami M; Masui M; Uno O; Ueda M
    Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4389-402. PubMed ID: 3246006
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis, pharmacological effects, and conformation of 4,4-disubstituted 1,4-dihydropyridines.
    Goldmann S; Born L; Kazda S; Pittel B; Schramm M
    J Med Chem; 1990 May; 33(5):1413-8. PubMed ID: 2329562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional vascular effects of MPC-1304, a novel dihydropyridine derivative, in conscious normotensive and spontaneously hypertensive rats.
    Miyoshi K; Kanda A; Nozawa Y; Nakano M; Miyake H
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1328-36. PubMed ID: 8667194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism of methyl (E)-3-phenyl-2-propen-1-yl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate (FRC-8411).
    Watanabe D; Fukutani T; Ikawa H; Yamaura T; Kase N; Mizutani H
    Chem Pharm Bull (Tokyo); 1986 Nov; 34(11):4855-8. PubMed ID: 3829202
    [No Abstract]   [Full Text] [Related]  

  • 33. MPC-1304, another type of dihydropyridine, possessing highly potent vasodilating action.
    Miyoshi K; Kanda A; Miyake H; Ichihara K; Kamei H; Nagasaka M
    Eur J Pharmacol; 1993 Jul; 238(2-3):139-48. PubMed ID: 7691619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chiral resolution and stereospecificity of 6-phenyl-4-phenylethynyl- 1,4-dihydropyridines as selective A(3) adenosine receptor antagonists.
    Jiang J; Li AH; Jang SY; Chang L; Melman N; Moro S; Ji X; Lobkovsky EB; Clardy JC; Jacobson KA
    J Med Chem; 1999 Aug; 42(16):3055-65. PubMed ID: 10447949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-(1-piperazinyl)-1H-1,2,4-triazol-3-amines as antihypertensive agents.
    Meyer WE; Tomcufcik AS; Chan PS; Haug M
    J Med Chem; 1989 Mar; 32(3):593-7. PubMed ID: 2918504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereoselective inhibition of thromboxane-induced coronary vasoconstriction by 1,4-dihydropyridine calcium channel antagonists.
    Eltze M; Boer R; Sanders KH; Boss H; Ulrich WR; Flockerzi D
    Chirality; 1990; 2(4):233-40. PubMed ID: 1964575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor occupation and pharmacokinetics of MPC-1304, a new Ca2+ channel antagonist, in spontaneously hypertensive rats.
    Nozawa Y; Miyake H; Yamada S; Uchida S; Ohkura T; Kimura R
    Eur J Pharmacol; 1995 Dec; 287(2):191-6. PubMed ID: 8749035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitrendipine: identification and synthesis of main metabolites.
    Meyer H; Scherling D; Karl W
    Arzneimittelforschung; 1983; 33(11):1528-34. PubMed ID: 6686447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 1st communication: comparative studies on the cardiovascular effects of methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2,3- b]pyridine-5-carboxylate and its two enantiomers in experimental animals.
    Ueda M; Matsumura S; Masui M; Matsuura E; Uno O; Kawakami M; Ninomiya M; Adachi I
    Arzneimittelforschung; 1993 Dec; 43(12):1270-5. PubMed ID: 8141813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.